Acrivon Therapeutics (ACRV) Q4 2025 Earnings

Nov 13Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.66
-0.6
-0.53
-0.47

Details

Expected EPS
-0.591111
Actual EPS
-0.47
Surprise EPS
0.12
Surprise Percent
+20.49%

Description

⁨Acrivon Therapeutics⁩ (⁦ACRV⁩) has reported earnings of ⁦-0.47⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts